Imvanex Vaccine

This contract, identified by solicitation number C449416, establishes an agreement between the Secretary of State for Health and Social Care, acting through the UK Health Security Agency, and Bavarian Nordic A/S for the supply of third-generation, UK Licensed Imvanex Smallpox Vaccine. The vaccines are intended for the UK countermeasures stockpile to ensure national preparedness. Due to single-supplier technical reasons, the procurement was conducted via a direct award. The contract was signed on September 30, 2026, with an initial term running from October 1, 2026, through September 30, 2029. There is a provision for a possible 12-month extension, which would extend the agreement until September 30, 2030. The agreement includes specific conditions regarding the order of precedence for schedules and formal notice requirements to govern the relationship between the agency and the supplier.